Ruth W. Brinkley Named to Diatherix Laboratories Board Of Directors

HUNTSVILLE, Ala., Feb. 12, 2015 /PRNewswire/ -- DIATHERIX Laboratories, Inc., one of the country's leading providers of molecular diagnostic services, today announced the appointment of Ruth W. Brinkley, FACHE, to its Board of Directors.

Brinkley has more than 40 years of healthcare experience working in private, public, academic, community-based and healthcare organizations. She currently serves as president and chief executive officer of KentuckyOne Health, Kentucky's largest health system, and as senior vice president of operations for Catholic Health Initiatives (CHI). At KentuckyOne Health, Brinkley oversees approximately 13,000 employees in more than 200 locations across the state of Kentucky and southern Indiana.

"Ruth has an impressive history of providing healthcare organizations across the country with keen strategic direction that results in improved operational performance and overall company growth," said Dennis Grimaud, CEO of DIATHERIX Laboratories. "We are proud to have her as a board member and her exceptional leadership experience and industry insight will be integral as we continue to position the company as one of the leading innovators in molecular diagnostics."

Prior to her role at KentuckyOne Health, Brinkley served as president and CEO of Carondelet Health Network, a part of Ascension Health and Southern Arizona's largest health system. In this position, Brinkley was responsible for overseeing Ascension's operations in Idaho and Washington. In previous years, Brinkley held several executive roles with CHI such as president and chief executive officer of Memorial Health Care System in Chattanooga, Tenn.; senior vice president for performance management for CHI nationally where she led system-wide operations improvements; and group vice president in Louisville, Ky.

Brinkley is a founding member of the Women Business Leaders of the U.S. Health Care Industry Foundation and is a frequent speaker on both healthcare delivery and leadership. She currently serves as a member of the Kentucky Health Benefit Exchange Advisory and is on the boards of DePaul University, Kentucky Chamber of Commerce and Greater Louisville, Inc. She is also a member of the National Association of Health Services Executives and the American College of Health Care Executives and was named one of the "10 Most Admired CEOs in Healthcare" in 2014 by Becker's Hospital Review and in 2010 and 2014 she was recognized as one of Modern Healthcare's "Top 25 Minority Executives in Healthcare." Brinkley holds Bachelor and Master of Science degrees in nursing from DePaul University and is a registered nurse.

ABOUT DIATHERIX
Diatherix Laboratories, Inc. is located in the HudsonAlpha Institute for Biotechnology in Huntsville, AL. Diatherix operates as an independent high complexity CLIA-certified clinical laboratory providing advanced multiplex molecular diagnostic services to assist healthcare providers in the detection of infectious diseases providing one-day results and single sample collection. For more information, please visit the company's website at www.diatherix.com.

MediaContact:Robin Embry
Lovell Communications
[email protected]
615-297-7766

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ruth-w-brinkley-named-to-diatherix-laboratories-board-of-directors-300035058.html

SOURCE DIATHERIX Laboratories, Inc.

Suggested Articles

A new clinical hold is the latest setback for Solid Biosciences and the development of its gene therapy for Duchenne muscular dystrophy.

VBI's Sci-B-Vac protected twice as many people than GSK's Engerix-B did after the second dose.

The notice comes weeks after Amgen revealed it was retreating from its East Coast neuroscience operations.